Los Angeles-based FUGO Precision 3D has announced it will showcase its commercial centrifugal 3D printing platform at LMT Lab Day 2026, the dental laboratory industry’s premier technology event scheduled for February in Chicago. The company positions itself as the developer of the world’s first patented centrifugal vat-photopolymerisation system, claiming to address long-standing workflow bottlenecks in additive manufacturing through integrated automation.
Leading the commercial push is co-founder and CEO Alexander Meseonznik, whose thirty-year entrepreneurial track record spans five ventures across diverse sectors. Meseonznik’s background centres not on technical innovation but on operational infrastructure – the systems, partnerships, and leadership frameworks that transform early-stage technology into market-ready products. His pattern has been identifying promising technical teams, then building the commercial apparatus around their innovations.
Centrifugal 3D Printing Integrates Post-Processing Automation
Meseonznik’s career has centred on recognising when a technology possesses genuine breakthrough potential, then assembling the resources required to commercialise it. His experience encompasses strategic partnerships, investor relations, acquisition structuring, and the financial oversight that enables companies to scale beyond prototype stages. When he encountered FUGO’s engineering team, he identified what he describes as a rare combination: genuinely novel technology paired with the need for business infrastructure.
The engineers had developed a centrifugal vat-photopolymerisation approach that fundamentally differs from conventional stereolithography methods. Rather than building parts vertically layer by layer, the system prints radially within a rotating cylindrical build volume, with parts forming from the outer wall inward toward the vat centre. FUGO claims this approach achieves print speeds up to 1mm per minute whilst eliminating visible layer lines through what it terms “concentric layer printing.”
Meseonznik’s role at FUGO has focused on translating technical capability into commercial execution. He assembled leadership across sales, finance, and operations, established go-to-market strategy, and cultivated partnerships positioning the company for dental, hearing health, aerospace, and defence applications. His contribution has been connecting engineering excellence with business infrastructure, aligning technical specifications with market requirements, and creating operational foundations for scale.
Strategic Partnership Strengthens Dental Market Position
FUGO recently announced a strategic partnership with Graphy Inc., a South Korean materials manufacturer listed on KOSDAQ. The collaboration integrates Graphy’s clinically validated, biocompatible Class II dental resins with FUGO’s platform, creating what both companies describe as a streamlined workflow for dental laboratories.
The system supports multi-colour printing within single build cycles, producing two-tone dentures and similar components without assembly steps. The build volume measures 1,276 x 200 x 100mm, accommodating production runs of dental prosthetics, hearing aid shells, surgical guides, and orthodontic appliances.
Meseonznik’s role at FUGO has focused on translating technical capability into commercial execution. He assembled leadership across sales, finance, and operations, established go-to-market strategy, and cultivated partnerships positioning the company for dental, hearing health, aerospace, and defence applications.
The company will conduct live demonstrations at LMT Lab Day 2026, printing complete dental components through full cycles including post-processing. FUGO is currently engaging pilot customers across target industries, with initial production unit delivery scheduled for Q1 2026.
About Manufactur3D Magazine: Manufactur3D is an online magazine on 3D Printing. Visit our Tech News page for more updates on 3D Printing Technology News. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on LinkedIn and Twitter.
